Danish expansion makes Novo Nordisk "a bigger and broader company"
The Danish drugmaker says the 340 new positions created by the expansion are already being filled.
by christopher due karlsson, translated by kristoffer grønbæk
It’s very much Novo Nordisk’s expanded focus on rare and chronic diseases that is the foundation of its just announced billion-dollar investment in the manufacturing facilities at Danish city Hillerød.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
